跳至主要内容
临床试验/NCT02137694
NCT02137694已完成不适用

Comparison of the Urinary and Vaginal Auto-takings for the Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer.

University Hospital, Brest4 个研究点 分布在 1 个国家目标入组 460 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
460
试验地点
4
主要终点
Research for human Papillomavirus by vaginal auto-takings and urinary test

研究概览

简要总结

Auto-takings by APU and vaginal APV during the consultations for FCU in the department of gynecology-obstetrics (Group 1) according to an instructions for use proposed to the inclusive women, with consent; the same proposal, APU and APV, is made for other consultations requiring a screening on the CHRU (Group 2: dermatology, endocrinology, ambulatory surgery, inner medicine, pneumology, oncology). Auto-takings transmitted in the laboratory of the CHRU of Brest for test HPV by quantitative real-time PCR. Results transmitted to the women and to the doctors of consultation. In case of positive test (15 %), the patients are directed to a gynecologist. Confrontation with the cytological data when available (Group 1) .

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • All the 25-65-year-old women requiring a screening and seen in consultation of the departments targeted by the CHRU of Brest

排除标准

  • Women except age limit, refusal to participate, hysterectomy, pregnancy and post-therapeutic follow-up.

结局指标

主要结局

Research for human Papillomavirus by vaginal auto-takings and urinary test

时间窗: 6 months

Estimate the research for human Papillomavirus ( HPV) in the vaginal auto-takings ( APV) and urinary ( APU) test at women from 25 to 65 years old requiring a screening.

次要结局

  • The global logistic of the study(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验